Tenesa Albert, Farrington Susan M, Prendergast James G D, Porteous Mary E, Walker Marion, Haq Naila, Barnetson Rebecca A, Theodoratou Evropi, Cetnarskyj Roseanne, Cartwright Nicola, Semple Colin, Clark Andrew J, Reid Fiona J L, Smith Lorna A, Kavoussanakis Kostas, Koessler Thibaud, Pharoah Paul D P, Buch Stephan, Schafmayer Clemens, Tepel Jürgen, Schreiber Stefan, Völzke Henry, Schmidt Carsten O, Hampe Jochen, Chang-Claude Jenny, Hoffmeister Michael, Brenner Hermann, Wilkening Stefan, Canzian Federico, Capella Gabriel, Moreno Victor, Deary Ian J, Starr John M, Tomlinson Ian P M, Kemp Zoe, Howarth Kimberley, Carvajal-Carmona Luis, Webb Emily, Broderick Peter, Vijayakrishnan Jayaram, Houlston Richard S, Rennert Gad, Ballinger Dennis, Rozek Laura, Gruber Stephen B, Matsuda Koichi, Kidokoro Tomohide, Nakamura Yusuke, Zanke Brent W, Greenwood Celia M T, Rangrej Jagadish, Kustra Rafal, Montpetit Alexandre, Hudson Thomas J, Gallinger Steven, Campbell Harry, Dunlop Malcolm G
Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and MRC Human Genetics Unit, Edinburgh EH4 2XU, UK.
Nat Genet. 2008 May;40(5):631-7. doi: 10.1038/ng.133. Epub 2008 Mar 30.
In a genome-wide association study to identify loci associated with colorectal cancer (CRC) risk, we genotyped 555,510 SNPs in 1,012 early-onset Scottish CRC cases and 1,012 controls (phase 1). In phase 2, we genotyped the 15,008 highest-ranked SNPs in 2,057 Scottish cases and 2,111 controls. We then genotyped the five highest-ranked SNPs from the joint phase 1 and 2 analysis in 14,500 cases and 13,294 controls from seven populations, and identified a previously unreported association, rs3802842 on 11q23 (OR = 1.1; P = 5.8 x 10(-10)), showing population differences in risk. We also replicated and fine-mapped associations at 8q24 (rs7014346; OR = 1.19; P = 8.6 x 10(-26)) and 18q21 (rs4939827; OR = 1.2; P = 7.8 x 10(-28)). Risk was greater for rectal than for colon cancer for rs3802842 (P < 0.008) and rs4939827 (P < 0.009). Carrying all six possible risk alleles yielded OR = 2.6 (95% CI = 1.75-3.89) for CRC. These findings extend our understanding of the role of common genetic variation in CRC etiology.
在一项全基因组关联研究中,为了确定与结直肠癌(CRC)风险相关的基因座,我们对1012例早发性苏格兰CRC病例和1012例对照(第一阶段)中的555,510个单核苷酸多态性(SNP)进行了基因分型。在第二阶段,我们对2057例苏格兰病例和2111例对照中的15,008个排名最靠前的SNP进行了基因分型。然后,我们对来自七个群体的14,500例病例和13,294例对照进行了第一阶段和第二阶段联合分析中排名最靠前的五个SNP的基因分型,并确定了一个先前未报告的关联,即位于11q23的rs3802842(比值比[OR]=1.1;P=5.8×10⁻¹⁰),显示出风险的人群差异。我们还在8q24(rs7014346;OR=1.19;P=8.6×10⁻²⁶)和18q21(rs4939827;OR=1.2;P=7.8×10⁻²⁸)处重复并精确绘制了关联。对于rs3802842(P<0.008)和rs4939827(P<0.009),直肠癌的风险高于结肠癌。携带所有六个可能的风险等位基因的CRC的OR=2.6(95%置信区间[CI]=1.75 - 3.89)。这些发现扩展了我们对常见基因变异在CRC病因学中作用的理解。